ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Viatris Inc. securities between August 8, 2024, and February 26, 2025, of the upcoming lead plaintiff deadline on June 3, 2025, for a class action lawsuit related to misleading statements about the company's Indore, India facility inspection [1][4]. Group 1: Class Action Details - Investors who purchased Viatris securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [2]. - The lawsuit alleges that Viatris provided misleading information regarding the FDA's warning letter and import alert affecting eleven products from its Indore facility, which were downplayed as a "minor headwind" [4][5]. Group 2: Misleading Statements and Financial Impact - Defendants allegedly failed to disclose critical information about the timing of the inspection, the duration of remediation efforts, and the financial implications of these actions [5]. - The lawsuit claims that the misleading statements led investors to purchase Viatris securities at artificially inflated prices, resulting in damages when the true details became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [3]. - The firm has been recognized for its leadership in securities class action settlements, including a notable settlement against a Chinese company [3].